摘要
目的观察肿瘤抑制基因p16、p53及细胞周期依赖激酶抑制物p21基因单独或联合应用时对肺癌细胞增殖的影响。方法应用十八酰基胺阳离子脂质体介导p16、p53、p21基因单独或共转染到非小细胞肺癌细胞系A549和小细胞肺癌细胞系SH77,观察转染后1、3、5日该细胞增殖的活力。采用四甲基偶氮唑盐微量酶反应比色法(MTT法)测定吸光度(A),以检测细胞增殖活力。结果A549细胞系:A均值分别为:空白组0.7856,脂质体组0.7478,p16组0.5589,p21组0.6022,p53组0.5778,p16+p21组0.4711,p16+p53组0.3017,实验组与对照组比较P<0.01,以共转染p16+p53组最强。SH77细胞系:A均值分别为:空白组1.0222,脂质体组0.9316,p16组0.9137,p21组0.8889,p53组0.8356,p16+p21组0.5933,p16+p53组0.4278,单转染实验组与对照组比较P>0.05;共转染实验组与对照组比较P<0.01,以p16+p53组更明显。结论p16、p53和p21基因有可能成为非小细胞肺癌基因替代治疗的候选基因,联合应用p16与p21基?
Objective Whether the p16, p21and p53 genes inhibit the proliferation of lung cancer cells after transfecting the genes alone or jointly was examined. Methods The p16 ,p21 and p53 genes mediated by Stearylamine/DOPE (SA liposome) were introduced alone and jointly into the non small cell lung cancer(NSCLC) cell line A549 and small cell lung cancer (SCLC) SH77.The effect of the genes on the growth of the cells was detected by MTT method at day 1,3,5 after gene transfection. Results The p16 , p53 and p21 genes alone mediated by SA liposome can inhibite obviously the growth of NSCLC cell line A549 cells, while the genes were slightly effective on SCLC cell line SH77 cells at day 1,3,5 after transfecting the genes. But co transfecting p16 and p21 or p16 and p53 can enhance the inhibiting effect on both A549 and SH77 cells significantly. Conclusions The tumor suppressor genes p16, p53 genes and CDK inhibitor p21 gene may be candidate for gene replacement therapy of NSCLC. Co transfecting p16 gene and p53 gene may be a better choice.
出处
《中华结核和呼吸杂志》
CAS
CSCD
北大核心
1999年第3期169-172,共4页
Chinese Journal of Tuberculosis and Respiratory Diseases
基金
国家自然科学基金